Broadfin Capital’s Cigna CI Stock Holding History

Broadfin Capital’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-42,600	Closed	-$7.15M	–	50
2018 Q1	$7.15M	Buy	+42,600	New	+$8.28M	1.11%	25

Other funds holding CI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Broadfin Capital's CI Position: Q2 2018 in Review

Broadfin Capital sold out of Cigna (CI) in Q2 2018, closing a stake of 42,600 shares — an estimated $7.15M sold.

Broadfin Capital first reported a position in CI in Q1 2018 and held it in 1 quarter. The position peaked at $7.15M in Q1 2018. 858 funds tracked by Wall St. Rank hold CI as of Q2 2018.

Broadfin Capital reported no remaining Cigna position as of Q2 2018 after selling out during the quarter.
Broadfin Capital sold 42,600 Cigna shares in Q2 2018, an estimated $7.15M.
Broadfin Capital first reported a position in Cigna in Q1 2018 and held it in 1 quarter.
Broadfin Capital's Cigna position peaked at $7.15M in Q1 2018.
858 funds tracked by Wall St. Rank held Cigna as of Q2 2018.

Based on Broadfin Capital's 13F filing for Q2 2018, filed 14 Aug 2018.